Siddharth Kumar Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Siddharth Kumar Patel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Amna Mbbs Soulat
Ziauddin Medical University
1 shared publication - Anmol Mohan
Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL, USA
1 shared publication - Hajar Fakhor
Asselin Hedelin Hospital, Yvetot, France
1 shared publication - Koushik Mbbs Majumder
Chittagong Medical College, Chittagong, Bangladesh
1 shared publication - Mashal Binte Ali
MountainView Regional Medical Center Las Cruces New Mexico USA
1 shared publication - Priyanka Mohan Lal
Department of Internal Medicine, Ziauddin University, Karachi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 17 January 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (3) , 1531-1539
Impact of artificial intelligence on the diagnosis, treatment and prognosis of endometrial cancer
Endometrial cancer is one of the most prevalent tumours in females and holds an 83% survival rate within 5 years of diagnosis. Hypoestrogenism is a major risk factor for the development of endometrial carcinoma (EC) therefore two major types are derived, type 1 being oestrogen-dependent and type 2 being oestrogen independent. Surgery, chemotherapeutic drugs, and radiation therapy are only a few of the treatment options for EC. Treatment of gynaecologic malignancies greatly depends on diagnosis or prognostic prediction. Diagnostic imaging data and clinical course prediction are the two core pillars of artificial intelligence (AI) applications. One of the most popular imaging techniques for spotting preoperative endometrial cancer is MRI, although this technique can only produce qualitative data. When used to classify patients, AI improves the effectiveness of visual feature extraction. In general, AI has the potential to enhance the precision and effectiveness of endometrial cancer diagnosis and therapy. This review aims to highlight the current status of applications of AI in endometrial cancer and provide a comprehensive understanding of how recent advancements in AI have assisted clinicians in making better diagnosis and improving prognosis of endometrial cancer. Still, additional study is required to comprehend its strengths and limits fully.
- 17 January 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (3) , 1531-1539
Open AccessImpact of artificial intelligence on the diagnosis, treatment and prognosis of endometrial cancer
Endometrial cancer is one of the most prevalent tumours in females and holds an 83% survival rate within 5 years of diagnosis. Hypoestrogenism is a major risk factor for the development of endometrial carcinoma (EC) therefore two major types are derived, type 1 being oestrogen-dependent and type 2 being oestrogen independent. Surgery, chemotherapeutic drugs, and radiation therapy are only a few of the treatment options for EC. Treatment of gynaecologic malignancies greatly depends on diagnosis or prognostic prediction. Diagnostic imaging data and clinical course prediction are the two core pillars of artificial intelligence (AI) applications. One of the most popular imaging techniques for spotting preoperative endometrial cancer is MRI, although this technique can only produce qualitative data. When used to classify patients, AI improves the effectiveness of visual feature extraction. In general, AI has the potential to enhance the precision and effectiveness of endometrial cancer diagnosis and therapy. This review aims to highlight the current status of applications of AI in endometrial cancer and provide a comprehensive understanding of how recent advancements in AI have assisted clinicians in making better diagnosis and improving prognosis of endometrial cancer. Still, additional study is required to comprehend its strengths and limits fully.